Patents by Inventor Gary C. Visor

Gary C. Visor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • mTOR inhibitor salt forms
    Patent number: 8557814
    Abstract: Salt forms of mTOR inhibitors of the Formula (I): and methods of preparation, formulation, and use in treating disease.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: October 15, 2013
    Assignee: OSI Pharmaceuticals, LLC
    Inventors: Arlindo L. Castelhano, Kristen Michelle Mulvihill, Gary C. Visor
  • STABLE PROSTAGLANDIN-CONTAINING COMPOSITIONS
    Publication number: 20120065258
    Abstract: A pharmaceutical composition containing a prostaglandin and an alkanoic acid ester of a polyethoxylated sorbitol in an amount effective to enhance the chemical stability of the prostaglandin, and the use thereof for treating ophthalmic conditions. Also disclosed are methods for enhancing the chemical stability of a prostaglandin-containing composition by using an alkanoic acid ester of a polyethoxylated sorbitol.
    Type: Application
    Filed: November 17, 2011
    Publication date: March 15, 2012
    Inventors: Victor Deaciuc, Michael Hagan, Hashem Heiati, Karen K. Jette, Gary C. Visor, Ian G.C. McAffer, Peter Tasko
  • Stable prostaglandin-containing compositions
    Patent number: 8084501
    Abstract: A pharmaceutical composition containing a prostaglandin and an alkanoic acid ester of a polyethoxylated sorbitol in an amount effective to enhance the chemical stability of the prostaglandin, and the use thereof for treating ophthalmic conditions. Also disclosed are methods for enhancing the chemical stability of a prostaglandin-containing composition by using an alkanoic acid ester of a polyethoxylated sorbitol.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: December 27, 2011
    Assignees: Breath Limited, Resolution Chemicals Limited
    Inventors: Victor Deaciuc, Michael Hagan, Hashem Heiati, Karen K. Jette, Gary C. Visor, Ian G. C. McAffer, Peter Tasko
  • mTOR INHIBITOR SALT FORMS
    Publication number: 20110015197
    Abstract: Salt forms of mTOR inhibitors of the Formula (I): and methods of preparation, formulation, and use in treating disease.
    Type: Application
    Filed: March 18, 2009
    Publication date: January 20, 2011
    Applicant: OSI Pharmaceuticals, Inc.
    Inventors: Arlindo L. Castelhano, Kristen Michelle Mulvihill, Josef A. Rechka, Gary C. Visor
  • Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins
    Patent number: 4837239
    Abstract: This invention is directed to a formulation of cardiotonic phosphodiesterase inhibitors with a water-soluble vitamin, comprising a lyophilization step performed on a solution of the complex in an aqueous/organic solvent system. The formulation results in a complex that has been found to have enhanced solubility (over the compound alone) in a parenterally or orally acceptable solvent, and the lyophilization process yields a product with superior stability permitting an extended shelf life.
    Type: Grant
    Filed: October 14, 1986
    Date of Patent: June 6, 1989
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Eric J. Benjamin, Gary C. Visor